| NCT03662750 |
TSPO PET as a Measure of Post-stroke Brain Inflammation: a Natural History Cohort |
https://ClinicalTrials.gov/show/NCT03662750 |
Recruiting |
Imperial College London |
2019-12-31 |
| NCT03826056 |
Neurology Inpatient Clinical Education Trial |
https://ClinicalTrials.gov/show/NCT03826056 |
Active, not recruiting |
Dartmouth-Hitchcock Medical Center |
2020-10-31 |
| NCT03282370 |
Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam |
https://ClinicalTrials.gov/show/NCT03282370 |
Completed |
National Institute of Hygiene and Epidemiology, Vietnam |
2018-02-06 |
| NCT03204227 |
Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age |
https://ClinicalTrials.gov/show/NCT03204227 |
Completed |
National Institute of Hygiene and Epidemiology, Vietnam |
2017-08-12 |
| NCT03194815 |
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2 |
https://ClinicalTrials.gov/show/NCT03194815 |
Recruiting |
University of Cambridge |
2020-12-31 |
| NCT03181945 |
Duration of Anti-convulsant Therapy for Acute Symptomatic Seizure in Acute Encephalitis Syndrome |
https://ClinicalTrials.gov/show/NCT03181945 |
Active, not recruiting |
Postgraduate Institute of Medical Education and Research |
2018-09-30 |
| NCT02910037 |
Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort |
https://ClinicalTrials.gov/show/NCT02910037 |
Completed |
University of California, San Francisco |
2017-07-31 |
| NCT02816554 |
Safety and Immunogenicity of JECEVAX in Young Children |
https://ClinicalTrials.gov/show/NCT02816554 |
Completed |
National Institute of Hygiene and Epidemiology, Vietnam |
2015-09-30 |
| NCT02654509 |
Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine |
https://ClinicalTrials.gov/show/NCT02654509 |
Completed |
U.S. Army Medical Research and Development Command |
2016-02-16 |
| NCT02643433 |
Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines |
https://ClinicalTrials.gov/show/NCT02643433 |
Completed |
Centers for Disease Control and Prevention, China |
2016-06-30 |
| NCT02602652 |
Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine |
https://ClinicalTrials.gov/show/NCT02602652 |
Completed |
Chulalongkorn University |
2015-07-31 |
| NCT02233868 |
Brain Inflammation and Function in Alcoholism |
https://ClinicalTrials.gov/show/NCT02233868 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2024-12-31 |
| NCT02538094 |
tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis |
https://ClinicalTrials.gov/show/NCT02538094 |
Completed |
Johns Hopkins University |
2019-06-30 |
| NCT02532569 |
Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj |
https://ClinicalTrials.gov/show/NCT02532569 |
Completed |
Boryung Pharmaceutical Co., Ltd |
2016-10-31 |
| NCT02526550 |
Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX |
https://ClinicalTrials.gov/show/NCT02526550 |
Completed |
Siriraj Hospital |
2014-07-31 |
| NCT02514746 |
Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose |
https://ClinicalTrials.gov/show/NCT02514746 |
Completed |
PATH |
2016-12-15 |
| NCT02511535 |
TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients |
https://ClinicalTrials.gov/show/NCT02511535 |
Completed |
Medical University of Vienna |
2016-02-29 |
| NCT02492165 |
Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02492165 |
Completed |
Sanofi |
2016-03-31 |
| NCT02479698 |
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus |
https://ClinicalTrials.gov/show/NCT02479698 |
Recruiting |
M.D. Anderson Cancer Center |
2020-07-31 |
| NCT02463942 |
Tick-borne Encephalitis and Positive Borrelial Antibodies |
https://ClinicalTrials.gov/show/NCT02463942 |
Recruiting |
University Medical Centre Ljubljana |
2020-09-30 |
| NCT02367664 |
A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants |
https://ClinicalTrials.gov/show/NCT02367664 |
Completed |
Jiangsu Province Centers for Disease Control and Prevention |
2016-06-30 |
| NCT02308982 |
Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis |
https://ClinicalTrials.gov/show/NCT02308982 |
Active, not recruiting |
University of Oxford |
2019-02-28 |
| NCT02186626 |
Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age |
https://ClinicalTrials.gov/show/NCT02186626 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-07-31 |
| NCT01296360 |
Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country |
https://ClinicalTrials.gov/show/NCT01296360 |
Completed |
Valneva Austria GmbH |
2011-11-30 |
| NCT02039440 |
6-year Antibody Check After Third Vaccination Against Japanese Encephalitis |
https://ClinicalTrials.gov/show/NCT02039440 |
Completed |
Medical University of Vienna |
2014-06-30 |
| NCT01991067 |
Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients |
https://ClinicalTrials.gov/show/NCT01991067 |
Completed |
Medical University of Vienna |
2018-10-28 |
| NCT01984983 |
Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01984983 |
Completed |
Ichor Medical Systems Incorporated |
2014-06-30 |
| NCT01981967 |
Post-licensure Safety Study of IMOJEV® in Thailand |
https://ClinicalTrials.gov/show/NCT01981967 |
Completed |
Sanofi |
2015-04-30 |
| NCT01943305 |
The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans |
https://ClinicalTrials.gov/show/NCT01943305 |
Completed |
Singapore General Hospital |
2015-06-30 |
| NCT01900444 |
Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea |
https://ClinicalTrials.gov/show/NCT01900444 |
Completed |
Sanofi |
2014-03-11 |
| NCT01856205 |
Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis |
https://ClinicalTrials.gov/show/NCT01856205 |
Completed |
University of Liverpool |
2009-08-31 |
| NCT01815073 |
Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine |
https://ClinicalTrials.gov/show/NCT01815073 |
Completed |
Changchun Keygen Biological Products Co., Ltd. |
2013-07-31 |
| NCT01662440 |
Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT01662440 |
Completed |
Novartis |
2012-12-31 |
| NCT01656200 |
A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 |
https://ClinicalTrials.gov/show/NCT01656200 |
Completed |
Indian Institute of Science |
2013-10-31 |
| NCT01582698 |
TBE Seropersistence up to 10 Years After First Booster in Adults |
https://ClinicalTrials.gov/show/NCT01582698 |
Completed |
Baxter Healthcare Corporation |
2015-06-30 |
| NCT01567865 |
Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine |
https://ClinicalTrials.gov/show/NCT01567865 |
Completed |
PATH |
2012-12-31 |
| NCT01562444 |
Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules |
https://ClinicalTrials.gov/show/NCT01562444 |
Completed |
GlaxoSmithKline |
2016-09-30 |
| NCT01466387 |
A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults |
https://ClinicalTrials.gov/show/NCT01466387 |
Completed |
Novartis |
2012-04-30 |
| NCT01408537 |
Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children |
https://ClinicalTrials.gov/show/NCT01408537 |
Completed |
Mahidol University |
2012-10-31 |
| NCT01398540 |
Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis Vaccine |
https://ClinicalTrials.gov/show/NCT01398540 |
Completed |
Medical University of Vienna |
2012-10-31 |
| NCT01396512 |
Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEVâ„¢) Compared to CD.JEVAXâ„¢ in Toddlers |
https://ClinicalTrials.gov/show/NCT01396512 |
Completed |
Sanofi |
2013-03-31 |
| NCT01386827 |
Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis |
https://ClinicalTrials.gov/show/NCT01386827 |
Completed |
Helsinki University Central Hospital |
2011-04-30 |
| NCT01361776 |
Humoral Response to Tick-borne Encephalitis Vaccine in Elderly |
https://ClinicalTrials.gov/show/NCT01361776 |
Completed |
Sormland County Council, Sweden |
2013-12-31 |
| NCT04361344 |
Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04361344 |
Recruiting |
Centre Hospitalier de PAU |
2021-01-19 |
| NCT04344626 |
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery |
https://ClinicalTrials.gov/show/NCT04344626 |
Recruiting |
University of California, Los Angeles |
2023-03-31 |
| NCT04343469 |
Effects of Morbid Obesity and Bariatric Surgery on Brain Inflammation, and Activation of Central Reward System |
https://ClinicalTrials.gov/show/NCT04343469 |
Recruiting |
Turku University Hospital |
2022-09-30 |
| NCT04325685 |
The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia |
https://ClinicalTrials.gov/show/NCT04325685 |
Active, not recruiting |
Northern State Medical University |
2021-12-31 |
| NCT04323150 |
The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia. |
https://ClinicalTrials.gov/show/NCT04323150 |
Recruiting |
Northern State Medical University |
2020-12-31 |
| NCT04223037 |
Purified Inactivated Japanese Encephalitis Vaccine |
https://ClinicalTrials.gov/show/NCT04223037 |
Active, not recruiting |
Chinese Academy of Medical Sciences |
2018-03-07 |
| NCT04137159 |
An Exercise Intervention to Reduce Neuropathic Pain and Brain Inflammation After Spinal Cord Injury |
https://ClinicalTrials.gov/show/NCT04137159 |
Recruiting |
Spaulding Rehabilitation Hospital |
2025-01-31 |
| NCT04131595 |
Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT04131595 |
Active, not recruiting |
Bavarian Nordic |
2020-06-30 |
| NCT04080921 |
Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis |
https://ClinicalTrials.gov/show/NCT04080921 |
Completed |
Vinmec Research Institute of Stem Cell and Gene Technology |
2019-06-30 |
| NCT04017052 |
Application of a TBE-Vaccine in Obese Persons |
https://ClinicalTrials.gov/show/NCT04017052 |
Active, not recruiting |
Medical University of Vienna |
2020-02-07 |
| NCT04002219 |
Efficacy Evaluation of the Mushroom Beverage on Emotion Regulation |
https://ClinicalTrials.gov/show/NCT04002219 |
Recruiting |
National Science Council, Taiwan |
2019-12-31 |
| NCT03993262 |
Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis |
https://ClinicalTrials.gov/show/NCT03993262 |
Recruiting |
Jena University Hospital |
2022-07-01 |
| NCT03971058 |
Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals. |
https://ClinicalTrials.gov/show/NCT03971058 |
Recruiting |
Medical University of Vienna |
2020-12-31 |
| NCT03956446 |
Tick-borne Encephalitis and Borrelial Antibodies in Serum |
https://ClinicalTrials.gov/show/NCT03956446 |
Recruiting |
University Medical Centre Ljubljana |
2020-12-31 |
| NCT03879603 |
VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03879603 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-02-26 |
| NCT03835728 |
Efficacy of Ocrelizumab in Autoimmune Encephalitis |
https://ClinicalTrials.gov/show/NCT03835728 |
Recruiting |
University of Texas Southwestern Medical Center |
2022-01-22 |
| NCT03776994 |
Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine |
https://ClinicalTrials.gov/show/NCT03776994 |
Active, not recruiting |
SRI International |
2020-07-31 |
| NCT03542279 |
Immunotherapy in Autoimmune Encephalitis |
https://ClinicalTrials.gov/show/NCT03542279 |
Recruiting |
Xuanwu Hospital, Beijing |
2021-12-31 |
| NCT03435861 |
Effect of Neflamapimod on Brain Inflammation in Alzheimer’s Disease Patients |
https://ClinicalTrials.gov/show/NCT03435861 |
Recruiting |
University Hospital, Toulouse |
2020-01-30 |
| NCT01246479 |
Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study |
https://ClinicalTrials.gov/show/NCT01246479 |
Completed |
Valneva Austria GmbH |
2012-10-31 |
| NCT01190228 |
Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV |
https://ClinicalTrials.gov/show/NCT01190228 |
Completed |
Sanofi |
2010-10-29 |
| NCT01188343 |
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers |
https://ClinicalTrials.gov/show/NCT01188343 |
Completed |
Sanofi |
2012-07-31 |
| NCT01159561 |
Western Equine Encephalitis Vaccine, Inactivated |
https://ClinicalTrials.gov/show/NCT01159561 |
Completed |
U.S. Army Medical Research and Development Command |
2011-08-31 |
| NCT01158599 |
This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population |
https://ClinicalTrials.gov/show/NCT01158599 |
Completed |
Valneva Austria GmbH |
2011-06-30 |
| NCT01150942 |
Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea |
https://ClinicalTrials.gov/show/NCT01150942 |
Completed |
Boryung Pharmaceutical Co., Ltd |
2012-09-30 |
| NCT01106482 |
An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE |
https://ClinicalTrials.gov/show/NCT01106482 |
Completed |
Novartis |
2011-05-31 |
| NCT01092507 |
A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers |
https://ClinicalTrials.gov/show/NCT01092507 |
Completed |
Sanofi |
2011-09-30 |
| NCT01041573 |
Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population |
https://ClinicalTrials.gov/show/NCT01041573 |
Completed |
Valneva Austria GmbH |
2011-02-28 |
| NCT01001988 |
Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers |
https://ClinicalTrials.gov/show/NCT01001988 |
Completed |
Sanofi |
2013-10-16 |
| NCT00982137 |
Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®) |
https://ClinicalTrials.gov/show/NCT00982137 |
Completed |
Sanofi |
2005-04-30 |
| NCT00981630 |
Study of Live Attenuated ChimeriVaxâ„¢-Japanese Encephalitis Vaccine |
https://ClinicalTrials.gov/show/NCT00981630 |
Completed |
Sanofi |
2006-02-28 |
| NCT00981175 |
A Study of ChimeriVaxâ„¢-JE Live Attenuated Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00981175 |
Completed |
Sanofi |
2004-06-30 |
| NCT00894686 |
Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401) |
https://ClinicalTrials.gov/show/NCT00894686 |
Completed |
Pfizer |
2017-05-10 |
| NCT00840801 |
Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children |
https://ClinicalTrials.gov/show/NCT00840801 |
Completed |
Pfizer |
2009-05-31 |
| NCT02880865 |
Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine |
https://ClinicalTrials.gov/show/NCT02880865 |
Completed |
PATH |
2017-05-19 |
| NCT01865578 |
Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis |
https://ClinicalTrials.gov/show/NCT01865578 |
Completed |
Charite University, Berlin, Germany |
2015-05-31 |
| NCT01710189 |
Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac |
https://ClinicalTrials.gov/show/NCT01710189 |
Completed |
University of Surrey |
2014-10-31 |
| NCT00804219 |
Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination |
https://ClinicalTrials.gov/show/NCT00804219 |
Completed |
Medical University of Vienna |
2010-11-30 |
| NCT01047839 |
Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries |
https://ClinicalTrials.gov/show/NCT01047839 |
Completed |
Valneva Austria GmbH |
2013-08-31 |
| NCT02466750 |
Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine |
https://ClinicalTrials.gov/show/NCT02466750 |
Recruiting |
U.S. Army Medical Research and Development Command |
2020-06-30 |
| NCT04175522 |
Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis: |
https://ClinicalTrials.gov/show/NCT04175522 |
Completed |
Green Cross Corporation |
2020-06-11 |
| NCT00776230 |
Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling |
https://ClinicalTrials.gov/show/NCT00776230 |
Completed |
Valneva Austria GmbH |
2010-06-30 |
| NCT00735644 |
Study of ChimeriVaxâ„¢-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines |
https://ClinicalTrials.gov/show/NCT00735644 |
Completed |
Sanofi |
2009-05-31 |
| NCT00716066 |
Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT00716066 |
Recruiting |
Fred Hutchinson Cancer Research Center |
2026-03-31 |
| NCT00694460 |
Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers |
https://ClinicalTrials.gov/show/NCT00694460 |
Completed |
Novartis |
2004-08-31 |
| NCT00621764 |
Immunogenicity and Safety of ChimeriVaxâ„¢ Japanese Encephalitis Vaccine in Thai Toddlers and Children |
https://ClinicalTrials.gov/show/NCT00621764 |
Completed |
Sanofi |
2009-12-31 |
| NCT00605085 |
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51 |
https://ClinicalTrials.gov/show/NCT00605085 |
Completed |
Valneva Austria GmbH |
NA |
| NCT00604708 |
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51 |
https://ClinicalTrials.gov/show/NCT00604708 |
Completed |
Valneva Austria GmbH |
2006-09-30 |
| NCT00596271 |
Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440 |
https://ClinicalTrials.gov/show/NCT00596271 |
Completed |
Valneva Austria GmbH |
2006-07-31 |
| NCT00595790 |
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51 |
https://ClinicalTrials.gov/show/NCT00595790 |
Completed |
Valneva Austria GmbH |
2006-02-28 |
| NCT00595465 |
Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51 |
https://ClinicalTrials.gov/show/NCT00595465 |
Completed |
Valneva Austria GmbH |
2008-02-29 |
| NCT00595309 |
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 |
https://ClinicalTrials.gov/show/NCT00595309 |
Completed |
Valneva Austria GmbH |
2009-10-31 |
| NCT00595270 |
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 |
https://ClinicalTrials.gov/show/NCT00595270 |
Completed |
Valneva Austria GmbH |
2007-09-30 |
| NCT00594958 |
Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51 |
https://ClinicalTrials.gov/show/NCT00594958 |
Completed |
Valneva Austria GmbH |
2007-04-30 |
| NCT00584805 |
Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine |
https://ClinicalTrials.gov/show/NCT00584805 |
Completed |
U.S. Army Medical Research and Development Command |
2016-06-27 |
| NCT00503529 |
TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223) |
https://ClinicalTrials.gov/show/NCT00503529 |
Completed |
Pfizer |
2010-07-31 |
| NCT00463684 |
Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age |
https://ClinicalTrials.gov/show/NCT00463684 |
Completed |
PATH |
2007-11-07 |
| NCT00463476 |
Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine |
https://ClinicalTrials.gov/show/NCT00463476 |
Completed |
PATH |
2007-11-01 |
| NCT00460486 |
Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule |
https://ClinicalTrials.gov/show/NCT00460486 |
Completed |
Pfizer |
2007-11-30 |
| NCT00452621 |
Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years |
https://ClinicalTrials.gov/show/NCT00452621 |
Completed |
Novartis |
NA |
| NCT00441259 |
Safety and Efficacy Study of ChimeriVaxâ„¢-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age |
https://ClinicalTrials.gov/show/NCT00441259 |
Completed |
Sanofi |
2011-02-28 |
| NCT00412516 |
Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine |
https://ClinicalTrials.gov/show/NCT00412516 |
Completed |
PATH |
2010-03-31 |
| NCT00387634 |
Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis’ TBE Vaccine for Adults in Adolescents and Adults |
https://ClinicalTrials.gov/show/NCT00387634 |
Completed |
Novartis |
2011-10-31 |
| NCT00381433 |
Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid |
https://ClinicalTrials.gov/show/NCT00381433 |
Completed |
Sarepta Therapeutics, Inc. |
2006-10-31 |
| NCT00367081 |
Treatment of Cerebral Toxoplasmosis in HIV/AIDS |
https://ClinicalTrials.gov/show/NCT00367081 |
Completed |
Rajavithi Hospital |
NA |
| NCT00319592 |
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX |
https://ClinicalTrials.gov/show/NCT00319592 |
Completed |
Sanofi |
2006-09-30 |
| NCT00314145 |
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxâ„¢-JE and JE-VAX |
https://ClinicalTrials.gov/show/NCT00314145 |
Completed |
Sanofi |
2006-06-30 |
| NCT00314132 |
Safety Study of ChimeriVaxâ„¢-JE Vaccine to Prevent Japanese Encephalitis. |
https://ClinicalTrials.gov/show/NCT00314132 |
Completed |
Sanofi |
2006-11-30 |
| NCT00311493 |
Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults |
https://ClinicalTrials.gov/show/NCT00311493 |
Completed |
Novartis |
NA |
| NCT00311441 |
Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children |
https://ClinicalTrials.gov/show/NCT00311441 |
Completed |
Novartis |
NA |
| NCT00259805 |
A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis |
https://ClinicalTrials.gov/show/NCT00259805 |
Completed |
California Pacific Medical Center Research Institute |
2008-12-31 |
| NCT00249769 |
Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine |
https://ClinicalTrials.gov/show/NCT00249769 |
Completed |
PATH |
2006-05-30 |
| NCT00163540 |
Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225) |
https://ClinicalTrials.gov/show/NCT00163540 |
Completed |
Pfizer |
NA |
| NCT00161967 |
TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209) |
https://ClinicalTrials.gov/show/NCT00161967 |
Completed |
Pfizer |
2008-07-31 |
| NCT00161954 |
Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years |
https://ClinicalTrials.gov/show/NCT00161954 |
Completed |
Pfizer |
NA |
| NCT00161889 |
FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years |
https://ClinicalTrials.gov/show/NCT00161889 |
Completed |
Pfizer |
NA |
| NCT00161876 |
FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years |
https://ClinicalTrials.gov/show/NCT00161876 |
Completed |
Pfizer |
NA |
| NCT00161863 |
Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years |
https://ClinicalTrials.gov/show/NCT00161863 |
Completed |
Pfizer |
NA |
| NCT00161850 |
FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years |
https://ClinicalTrials.gov/show/NCT00161850 |
Completed |
Pfizer |
NA |
| NCT00161824 |
Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR |
https://ClinicalTrials.gov/show/NCT00161824 |
Completed |
Pfizer |
NA |
| NCT00161798 |
Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years. |
https://ClinicalTrials.gov/show/NCT00161798 |
Completed |
Pfizer |
NA |
| NCT00161785 |
Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years |
https://ClinicalTrials.gov/show/NCT00161785 |
Completed |
Pfizer |
NA |
| NCT00161772 |
Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years. |
https://ClinicalTrials.gov/show/NCT00161772 |
Completed |
Pfizer |
NA |
| NCT00161746 |
Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years |
https://ClinicalTrials.gov/show/NCT00161746 |
Completed |
Pfizer |
NA |
| NCT00118924 |
Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00118924 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-07-31 |
| NCT00094718 |
Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3’delta30) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00094718 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-04-30 |
| NCT00068055 |
IVIG - West Nile Encephalitis: Safety and Efficacy |
https://ClinicalTrials.gov/show/NCT00068055 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-12-31 |
| NCT00031486 |
Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir |
https://ClinicalTrials.gov/show/NCT00031486 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2010-06-30 |
| NCT00002064 |
Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse |
https://ClinicalTrials.gov/show/NCT00002064 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00001994 |
A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine |
https://ClinicalTrials.gov/show/NCT00001994 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00000794 |
Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis |
https://ClinicalTrials.gov/show/NCT00000794 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000674 |
A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00000674 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000666 |
A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection |
https://ClinicalTrials.gov/show/NCT00000666 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |